According to local media outlet Manila Times on May 5th, consumer groups and advocates for reducing tobacco harm in the Philippines have welcomed comments from the US Food and Drug Administration's Center for Tobacco Products (FDA-CTP). The FDA-CTP concluded in their comments that the health risks of smokeless tobacco products are lower than those of cigarettes.
The Food and Drug Administration's Center for Tobacco Products (FDA-CTP) has released a commentary titled "Nicotine E-cigarettes: Considerations for Providers of Health Security.
This comment points out that "non-combustible tobacco products, such as e-cigarettes, generally pose lower health risks to users than combustible tobacco products.
This conclusion immediately sparked strong reactions from consumer groups in the Philippines and advocates for reducing tobacco harm. They welcomed the conclusion from the U.S. Food and Drug Administration's Center for Tobacco Products (FDA-CTP), believing it will have a positive impact on promoting the use of smoke-free products.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
